Acrodermatitis chronica atrophicans

From WikiMD's WELLNESSPEDIA

(Redirected from Herxheimer disease)


Acrodermatitis chronica atrophicans
Synonyms ACA
Pronounce N/A
Specialty N/A
Symptoms Skin discoloration, atrophy, neuropathy
Complications Peripheral neuropathy, skin cancer
Onset Months to years after initial Borrelia burgdorferi infection
Duration Chronic
Types N/A
Causes Borrelia afzelii infection
Risks Tick exposure, Lyme disease
Diagnosis Clinical diagnosis, serology
Differential diagnosis Scleroderma, Morphea, Lichen sclerosus
Prevention Tick bite prevention, early treatment of Lyme disease
Treatment Antibiotics such as doxycycline or amoxicillin
Medication Doxycycline, Amoxicillin
Prognosis Variable, can lead to permanent skin changes
Frequency Rare
Deaths N/A


Acrodermatitis chronica atrophicans is a skin condition, and as the name suggests, it leads to chronic atrophy of the skin and polyneuropathy.

Bacterial infection[edit]

This progressive skin condition caused by spirochete Borrelia afzelii, and to some lesser degree, B. afzelii, and Borrelia garinii.

Clinical presentation[edit]

The skin rash is seen most commonly on extremities.

Stages[edit]

  • It begins with an inflammatory stage and later with an atrophic phase.
  • Sclerotic skin plaques may also develop.
  • ACA progresses the skin begins to wrinkle.

Testing[edit]

1)Screening test- IgM and IgG ELISA 2) If 1 is positive or there is high clinical suspicion in spite of Elisa being negative than confirmatory test - Western Blot.

Other methods[edit]

Microscopy and culture (in modified Kelly's medium) of skin biopsy or blood samples.

Treatment[edit]

Doxycycline[edit]

Treatment consists of antibiotics including doxycycline and penicillin for up to four weeks in the acute case and sometimes longer.

See also[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.